Literature DB >> 24594090

Higher insertion success with the i-gel supraglottic airway in out-of-hospital cardiac arrest: a randomised controlled trial.

Paul MacConachie Middleton1, Paul Michael Simpson2, Richard E Thomas3, Jason Charles Bendall4.   

Abstract

BACKGROUND: Since their emergence from the operating theatre over a decade ago, supra-glottic airways (SGA) have become increasingly common in the management of out-of-hospital cardiac arrest (OOHCA) with laryngeal masks (LM) the most common SGA. The proliferation of LMs in the prehospital setting has occurred despite lower than expected rates of successful insertion being reported.
METHODS: We conducted a single-centre, prospective parallel-group, 'open label' randomised controlled trial in subjects with OOHCA (aged greater than or equal to 12 years of age; weighing greater than or equal to 30 kg) were allocated to either the i-gel supraglottic airway (IG-SGA) or the Portex Soft Seal Laryngeal Mask (PSS-LM) within a large Australian ambulance service. Our hypothesis was that use of the IG-SGA, when compared to the Portex PSS-LM, would result in a higher rate of successful insertion in patients presenting with OOHCA. The primary outcome was successful insertion of the SGA. MAIN
FINDINGS: There were 51 patients randomised. Subjects had an average age of 65 years and 40% were female. There were no apparent differences in key demographic characteristics between groups. The IG-SGA had a significantly higher success rate than the PSS-LM (90% versus 57%; p=0.023), resulting in a 58% greater likelihood of successful insertion than the PSS-LM (RR 1.58; 95% CI 1.11-2.24). The IG-SGA was associated with significantly lower median "ease of insertion" scores.
CONCLUSION: The i-gel supraglottic airway was associated with higher successful insertion rates in subjects with out-of-hospital cardiac arrest.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Airway management; Controlled clinical trial; Laryngeal mask; Out of hospital cardiac arrest; Paramedics; Prehospital emergency care

Mesh:

Year:  2014        PMID: 24594090     DOI: 10.1016/j.resuscitation.2014.02.021

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

Review 1.  [The supraglottic airway in the prehospital setting].

Authors:  H-R Arntz; J Breckwoldt
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09-04       Impact factor: 0.840

2.  Comparison of I-gel with Classic Laryngeal Mask Airway Regarding the Ease of Use and Clinical Performance.

Authors:  Dilek Erdoğan Arı; Arzu Yıldırım Ar; Ceren Şanlı Karip; İncifer Siyahkoç; Ahmet Hakan Arslan; Fatma Nur Akgün
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-08-21

3.  Cluster cross-over randomised trial of paediatric airway management devices in the simulation lab and operating room among paramedic students.

Authors:  Matthew Lee Hansen; Adam Wagner; Ashley Schnapp; Amber Lin; Nancy Le; Sarah Deverman; Elizabeth Pedigo; Andrea Johnson; Jordan Cusick; Heike Gries; Meredith Kato
Journal:  Emerg Med J       Date:  2020-10-12       Impact factor: 2.740

4.  Conversion of I-gel to definitive airway in a cervical immobilized manikin: Aintree intubation catheter vs long endotracheal tube.

Authors:  Yun Jeong Chae; Heirim Lee; Bokyeong Jun; In Kyong Yi
Journal:  BMC Anesthesiol       Date:  2020-06-18       Impact factor: 2.217

5.  Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial.

Authors:  Loric Stuby; Laurent Jampen; Julien Sierro; Maxime Bergeron; Erik Paus; Thierry Spichiger; Laurent Suppan; David Thurre
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

6.  Effect on Chest Compression Fraction of Continuous Manual Compressions with Asynchronous Ventilations Using an i-gel® versus 30:2 Approach during Simulated Out-of-Hospital Cardiac Arrest: Protocol for a Manikin Multicenter Randomized Controlled Trial.

Authors:  Loric Stuby; Laurent Jampen; Julien Sierro; Erik Paus; Thierry Spichiger; Laurent Suppan; David Thurre
Journal:  Healthcare (Basel)       Date:  2021-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.